Pharma Aids Limited

PHARMAID

BD0462PHAID7

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 29/05/2024 BST			5-day change	1st Jan Change
675.1 ^BDT	+0.54%		-1.21%	-14.62%

04-24	Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
01-30	Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Pharma Aids Limited Announces Cash Dividend for the Year Ended June 30, 2018

November 06, 2018 at 10:04 am

The Board of Directors of Pharma Aids Limited has recommended 50% cash dividend for the year ended on June 30, 2018.

Latest news about Pharma Aids Limited

Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-24	CI
Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	01-30	CI
Pharma Aids Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Pharma Aids Limited Reports Earnings Results for the Full Year Ended June 30, 2023	11-08	CI
Pharma Aids Limited Recommends Cash Dividend for the Year Ended June 30, 2023	11-08	CI
Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	30/04/23	CI
Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	22/01/23	CI
Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	22/01/23	CI
Pharma Aids Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	14/11/22	CI
Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	28/04/22	CI
Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	30/01/22	CI
Pharma Aids Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	14/11/21	CI
Pharma Aids Limited Recommends Cash Dividend for the Year Ended on June 30, 2021	10/11/21	CI
Pharma Aids Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	29/04/21	CI
Pharma Aids Limited Recommends Cash Dividend for the Year Ended on June 30, 2020	10/11/20	CI
Pharma Aids Limited Announces Earnings Results for the Year Ended June 30, 2020	10/11/20	CI
Pharma Aids Limited Announces Earnings Results for the Second Quarter and Half Year Ended December 2019	30/01/20	CI
Pharma Aids Limited Recommends Cash Dividend for the Year Ended on June 30, 2019	06/11/19	CI
Pharma Aids Limited Announces Cash Dividend for the Year Ended June 30, 2018	06/11/18	CI
Pharma Aids Limited Announces the Earnings Results for the Year Ended June 30, 2018	06/11/18	CI
Pharma Aids Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	02/05/18	CI
Pharma Aids Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 2017	31/01/18	CI
Pharma Aids Limited Announces Un-Audited Earnings Results for the First Quarter Ended September, 2017	14/11/17	CI
Pharma Aids Limited Reports Un-Audited Earnings Results for the Year Ended June 30, 2017	11/11/17	CI
Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 2017	01/05/17	CI

Pharma Aids Limited is a Bangladesh-based company, which is engaged in manufacturing and supplying of neutral glass ampoules. The Company primarily manufactures USP Type-I ampoules. These ampoules are used by pharmaceutical companies for filling liquid injections. The Company also produces different sizes of ampoules from one milliliter (ml) to 25ml, in clear and amber color, and of both open mouth (Form B and C) and close mouth (Form D, Din and Marzocchi type). Its ampoules can also be printed with customizable product descriptions, with a color break ring (CBR) break system at the constriction, and up to three color code/show-ring at the stem. The Company also has facility to produce flame-cut/opti-cut ampoules.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PHARMA AIDS LIMITED	-14.62%	17.94M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B